PL Voices
91 - 105 of
123 Results
Sort Results:
Article:
Experts will debate whether gliptins (Onglyza, etc) increase cardiovascular risk in patients with type 2 diabetes
November 2013
Guideline:
Hypoglycemia and Diabetes: a Report of a Workgroup of the American Diabetes Association and the Endocrine Society (2013)
August 2013